Burden of moderate-to-severe atopic dermatitis on work productivity and the impact of dupilumab on work productivity in Japanese patients: A single-center retrospective study

被引：0
|
作者：
Sakurai, Emi [1 ]
Kamata, Masahiro [1 ]
Uchida, Hideaki [1 ]
Tada, Yayoi [1 ]
机构：
[1] Teikyo Univ, Sch Med, Tokyo, Japan
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
41898
引用
收藏
页码：AB23 / AB23
页数：1
相关论文
共 50 条
  • [31] Long-term, observational, real-world study of dupilumab for the treatment of moderate-to-severe atopic dermatitis: a 52-week single-center retrospective analysis in China
    Deng, Sisi
    Wang, Huan
    Chen, Qiquan
    Chen, Xueqin
    Song, Xiao
    Chen, Shuguang
    Kong, Minmin
    Song, Zhiqiang
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (06)
  • [32] Impact of dupilumab treatment on seasonal disease severity in adults with moderate-to-severe atopic dermatitis
    Beck, Lisa A.
    Simpson, Eric L.
    Ramien, Michele
    Tang, Mark
    Joyce, Joel C.
    Praestgaard, Amy
    Rossi, Ana B.
    Clearfield, Drew
    Zhang, Annie
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [33] Impact of tanezumab on health status, non-work activities and work productivity in adults with moderate-to-severe osteoarthritis
    Philip G. Conaghan
    Lucy Abraham
    Lars Viktrup
    Paul Cislo
    BMC Musculoskeletal Disorders, 23
  • [34] Impact of tanezumab on health status, non-work activities and work productivity in adults with moderate-to-severe osteoarthritis
    Conaghan, Philip G.
    Abraham, Lucy
    Viktrup, Lars
    Cislo, Paul
    BMC MUSCULOSKELETAL DISORDERS, 2022, 23 (01)
  • [35] Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2
    Gil Yosipovitch
    Melinda J. Gooderham
    Sonja Ständer
    Luz Fonacier
    Jacek C. Szepietowski
    Mette Deleuran
    Giampiero Girolomoni
    John C. Su
    Andrew G. Bushmakin
    Joseph C. Cappelleri
    Claire Feeney
    Gary Chan
    Andrew J. Thorpe
    Hernan Valdez
    Pinaki Biswas
    Ricardo Rojo
    Marco DiBonaventura
    Daniela E. Myers
    American Journal of Clinical Dermatology, 2024, 25 : 127 - 138
  • [36] Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2
    Yosipovitch, Gil
    Gooderham, Melinda J.
    Staender, Sonja
    Fonacier, Luz
    Szepietowski, Jacek C.
    Deleuran, Mette
    Girolomoni, Giampiero
    Su, John C.
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Feeney, Claire
    Chan, Gary
    Thorpe, Andrew J.
    Valdez, Hernan
    Biswas, Pinaki
    Rojo, Ricardo
    Dibonaventura, Marco
    Myers, Daniela E.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2024, 25 (01) : 127 - 138
  • [37] Early Impact of Dupilumab in Disease Severity and Quality of Life of Patients Affected by Moderate-to-severe Atopic Dermatitis: A Prospective Study
    Garriga-Martina, G. G.
    Suarez-Perez, J. A.
    Martinez-Garcia, E. A.
    Herrera-Acosta, E.
    ACTAS DERMO-SIFILIOGRAFICAS, 2024, 115 (10): : 1031 - 1033
  • [38] Abrocitinib improves work productivity through improvement in pruritus and sleep: Results from the JADE MONO-2 study in patients with moderate-to-severe atopic dermatitis (AD)
    Yosipovitch, Gil
    Deleuran, Mette
    Su, John
    Fonacier, Luz
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Feeney, Claire
    Thorpe, Andrew
    Rojo, Ricardo
    Valdez, Hernan
    Myers, Daniela E.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB153 - AB153
  • [39] Switching from dupilumab to abrocitinib in patients with moderate-to-severe atopic dermatitis: an analysis of responders and nonresponders to dupilumab
    Silverberg, Jonathan, I
    Simpson, Eric L.
    Thyssen, Jacob P.
    Pink, Andrew E.
    Weidinger, Stephan
    Chan, Gary
    Lazariciu, Irina
    Clibborn, Claire
    Guler, Erman
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [40] Nemolizumab in moderate to severe atopic dermatitis: An exploratory analysis of work productivity and activity impairment in a randomized phase II study
    Mihara, Ryosuke
    Kabashima, Kenji
    Furue, Masutaka
    Nakano, Miwa
    Ruzicka, Thomas
    JOURNAL OF DERMATOLOGY, 2019, 46 (08): : 662 - 671
12345